 Are you tired of watching boring old press releases? Then you've come to the right place, the right channel, the number one channel for CEO interviews and company overviews. Welcome to Rich TV Live, subscribe to our channel and make sure to hit the like button on our videos to help with the YouTube algorithm for more information and in-depth discussions and analysis. Join our trading club at richpigsdaily.com and don't forget to subscribe and hit the bell for notifications to get alerted when our next CEO interview is released so you can discover the next 10-bagger. Hi, how are you doing today? I'm your host Rich, here on behalf of Rich TV Live with our very special guest. It's Wayne Coburn, the president of Pathway Health. How are you doing today, Wayne? Doing very well, thanks, how are you? I'm doing great, thank you for joining us. Wayne, maybe you can tell us a little bit about yourself and how you got involved with Pathway Health. Sure, so I first heard about Pathway Health back in 2018 when the company was in the early stages of transforming itself into a full interdisciplinary pain management business. I thought their strategy at the time was really well thought out and I was also impressed with the people involved and neither of these facts have changed. As far as my background, I've been in and around the healthcare business for over 25 years now and prior to that, I was in the investment business for over 10 years. I've been involved in capital markets in total now for hard to believe over 35 years and I have experienced in taking companies public in both Canada and the United States. Very exciting and can you tell us with this new IPO that's gonna be going public what your goals are, your main goals for the first six months for Pathway Health? Sure, well our goals for the first six months of being a public company really aren't any different than they were when I joined the company back in 2019. We have a number of initiatives underway but they all essentially feed into our three main goals which are to continue to aggregate patients, bring patients together through acquisitions and referrals to sign partnership agreements with as many Canadian pharmacy companies as we can. Certainly before the next round of Health Canada changes to the Cannabis Act. And finally to continue to expand our product and service offerings to our patients, our customers and our pharmacy partners. It's very important to have a very strong team. Can you go through your management and directors and especially talk a little bit about their success in the pain management sector and the public markets? Yeah, well, we're very fortunate to have a senior leadership team that's made up of experienced executives, all of them with healthcare and operational experience. Three of our top executives for example, have more than 20 years experience each in healthcare including pain management. Four of us have more than 25 years experience each in mergers and acquisitions. And two of us have more than 20 years of capital market experience including taking companies public in both Canada and the United States. Can you give our viewers an idea of how big the pain management sector is especially with more alternative approaches available now compared to the old traditional methods? Yeah, the pain management sector is enormous as you can imagine. If you're an adult and you don't have some chronic pain the chances are you know quite a few people who do. It affects one in five Canadians and this number is pretty consistent right across all developed countries. In terms of dollar value, the numbers vary and it depends on where you get your information from. But the one consistent statistic across all platforms is that the direct and indirect costs associated with chronic pain are more than cancer, diabetes and heart disease combined. So it's an enormous sector. What is the projected growth of this sector and how much of it do you think pathway health can capture? Well, most people believe the size of this sector is gonna continue to grow because of an aging population. But having said that, it's very difficult to put a number on what the rate of growth will be. Is it 5% is it 10%? The way I would characterize it is that the rate of growth of the sector is linked directly to the rate of growth of the general population. And in particular, the rate of growth of people 50 years of age or greater. This also makes it challenging to estimate how much of the overall market pathway health can actually capture. Because in some parts of our market, there are limiting factors such as the availability, for example, of specialists to treat patients. But having said all that, we can more easily measure the change in trends of treatment patterns with chronic pain patients, particularly among those who are more and more inclined to get involved in choosing the treatments that they receive. For example, over the past number of years, chronic pain patients are choosing to integrate more natural approaches to pain management in with what would be called more traditional modalities of pain. And that includes the use of opioids. And I think it's more independent evidence of efficacy of these natural approaches come to the forefront. You're gonna see a lot more physicians and other health care workers become more supportive of this integrative or interdisciplinary approach. If pathway health were to compare itself to its competitors in the sector, what would you say sets you guys apart? I think that there are two things that really set us apart from our competitors. The first would be the range of products and pain services that we can offer our patients is much broader than our major competitors. And here I'm talking about the traditional methods of treating chronic pain. The second thing I think that sets us apart is our experience and independence when talking about medical cannabis and chronic pain. We're the largest provider of medical cannabis services in the country, which means we've had more experience than anyone else. And to my knowledge, I don't believe any of our competitors have the relationships with the pharmacy companies that we do. And this I hope should become more apparent after the next round of changes to the Cannabis Act by Health Canada. It's extremely important here at Rich TV Live and we've got investors all over the world that are gonna be learning about pathway health to understand the share structure. Can you break down the share structure for our viewers and how the company intends to attract institutional investment as well as retail investment? Sure, we currently have 93 million shares, common shares outstanding of which approximately 56% are held by insiders. And these shares are all subject to a three-year escrow agreement. So they're locked up. Fully diluted, there are approximately 113 and a half million shares outstanding, but none of these derivatives securities are exercisable at less than 50 cents per share, which is the price that we did our going public round back in March. In terms of attracting, in terms of attracting institutional investors, I believe that we need to show them one or two quarters of performance before they'd be willing to commit. We'll also need to demonstrate liquidity in our shares so that they feel confident that they can sell their shares as easily as they can buy them. And then finally, if we're successful in gaining research coverage on pathway, I think this will also help in attracting institutional investors. If there was one thing you would want to share with us now about pathway health today, would that be? That's a great question. I'm glad you asked it. Based on things that we're hearing about the next round of Health Canada changes to the Cannabis Act, I believe the focus is going to be on medical. As part of these changes, I think that cannabis derivative products, such as CBD and CBG, are going to be made available to consumers through retail pharmacy stores across Canada. And when this happens, ask yourself what companies are likely to benefit from this. I believe pathway health is well positioned to benefit from these changes on a few fronts, including our relationships, our existing relationships rather with Canadian pharmacy companies. And we hope to expand these relationships to include working together on cannabis health products. So I believe that we're going to be in a really good position to benefit from what is likely to become a new consumer packaged goods category once these changes to the cannabis act are made. That sounds great. What is the best way for shareholders that are going to be watching this video to get in contact with the company if they have any questions? Well, I'd have them go to our website and register their name on our investor tab, or they can reach out to the Howard Group, which is the investor relations group that we're working with, or they're certainly welcome to reach out to me directly. Super excited to see you guys launch. Thank you so much for your time today. Wayne Coburn, the president of Pathway Health. Thank you very much for having me today. Always a pleasure. Now remember, if you like Rich TV Live, smash the like button, comment down below, share the video everywhere and subscribe. And Rich TV Live is strictly for information education purposes. Please do your due diligence, do your research before you invest in anything that we talk about here on Rich TV Live in saying that, I do believe that because this is a brand new company that it is undervalued, under-appreciated, under-exposed, put on your watch list, put on your radar, and thank you for watching. This is your boy, Rich from Rich TV Live, saying, have a nice day.